Cell-Based Assay Platforms are Evolving to Meet Diverse Challenges Cell-based assay platforms are evolving to meet diverse challenges—mimicking disease states, preserving signaling pathways, modeling ...

Discover how robust screening assays enhance data quality and reliability in high-throughput screening for drug discovery.

An ELRIG webinar has explored how cell-based screening supports drug discovery, from early target validation to advanced ...

Biochemical assays isolate a defined molecular interaction, while cell-based screening assays capture integrated cellular responses. Each format offers unique advantages and limitations within HTS ...

BIOLOGICAL assays may be divided into two main classes. In the first, which we may call Type I, the 'potency' of the test material, as compared with that of a standard preparation, refers only to its ...

SAN DIEGO--(BUSINESS WIRE)--Biological Dynamics, Inc., a multiomics liquid biopsy company focused on detecting cancers at the earliest stages, today announced that the U.S. Food and Drug ...

Assessing the safety and efficacy of biotherapeutics is imperative during the drug development process. In particular, pharmacokinetic (PK) and anti-drug antibody (ADA) assays are conducted to study ...

Microbial assays are a technique to assess a compound’s potency or concentration. This is carried out by exposing microorganisms to the compound and determining its effect on them. Microbial assays ...

Potency assay development uses DoE and QbD to improve accuracy, consistency, and regulatory readiness in biologics testing.

Enzyme assays are evolving from traditional spectrophotometric methods to high-throughput, AI-powered platforms that accelerate drug discovery, diagnostics, and sustainable chemistry. Advances like ...